Morgan Stanley Downgrades Icade to Equal-weight, Lowers Price Target to €25 as Catalysts Fade
Morgan Stanley has trimmed its rating on French real estate group Icade to Equal-weight from Overweight and reduced its price target to €25 from €30, citing limited near-term catalysts after the company's latest results. The broker pointed to a slower-than-expected exit from the healthcare business and revised dividend assumptions, factors that wei…